Clinical Trial Update: Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates

View source ↗

Summary

An ongoing Ain Shams University clinical trial examines whether prostaglandin E2 metabolite levels predict the development of hemodynamically significant patent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus
• Preterm Birth

Snippet

Sponsor: Ain Shams University | Conditions: Neonatal Prematurity, Patent Ductus Arteriosus in Preterm Infants | Status: RECRUITING